Iron metabolism in K562 erythroleukemic cells.
Iron delivery to K562 cells is enhanced by desferrioxamine through induction of transferrin receptors. Experiments were performed to further characterize this event with respect to iron metabolism and heme synthesis. In control cells, up to 85% of the iron taken up from iron-transferrin was incorporated into ferritin, 7% into heme, and the remainder into compartments not yet identified. In cells grown with desferrioxamine, net accumulation of intracellular desferrioxamine (14-fold) was observed and iron incorporation into ferritin and heme was inhibited by 86% and 75%, respectively. In contrast, complete inhibition of heme synthesis in cells grown with succinylacetone had no effect on transferrin binding or iron uptake. Exogenous hemin (30 microM) inhibited transferrin binding and iron uptake by 70% and heme synthesis by 90%. These effects were already evident after 2 h. Thus, although heme production could be reduced by desferrioxamine, succinylacetone, and hemin, cell iron uptake was enhanced only by the intracellular iron chelator. The effects of exogenous heme are probably unphysiologic and the greater inhibition of iron flow into heme can be explained by effects on early steps of heme synthesis. We conclude that in this cell model a chelatable intracellular iron pool rather than heme synthesis mediates regulation of iron uptake.
Bottomley
S S
SS
Wolfe
L C
LC
Bridges
K R
KR
D002460:Cell Line; D003676:Deferoxamine / Q000378:metabolism; D006418:Heme / Q000096:biosynthesis; D006537:Heptanoates / Q000494:pharmacology; D006801:Humans; D007501:Iron / Q000378:metabolism*; D004915:Leukemia, Erythroblastic, Acute / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism; D011990:Receptors, Transferrin; D014168:Transferrin / Q000378:metabolism
D006537:Heptanoates; D011956:Receptors, Cell Surface; D011990:Receptors, Transferrin; D014168:Transferrin; D006418:Heme; C020804:succinylacetone; D007501:Iron; D003676:Deferoxamine